We are live on ! Find out more
PCVX icon

Vaxcyte
PCVX

74 hedge funds and large institutions have $868M invested in Vaxcyte in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 13 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

36,000% more call options, than puts

Call options by funds: $361K | Put options by funds: $1K

200% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 13

2.82% more ownership

Funds ownership: 82.95% → 85.76% (+2.8%)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

11% less funds holding

Funds holding: 83 → 74 (-9)

22% less capital invested

Capital invested by funds: $1.12B → $868M (-$251M)

50% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 18

Holders
74
Holders Change
-9
Holders Change %
-10.84%
% of All Funds
1.3%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
9
Increased
39
Reduced
13
Closed
18
Calls
$361K
Puts
$1K
Net Calls
+$360K
Net Calls Change
+$360K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$33.3M
2
State Street
State Street
Massachusetts
+$21.4M
3
BlackRock
BlackRock
New York
+$12.5M
4
SCM
Soleus Capital Management
Connecticut
+$7.39M
5
IC
Ikarian Capital
Texas
+$5.66M

Top Sellers

Rank Fund Capital Flow
1
PBPIA
Pivotal bioVenture Partners Investment Advisor
California
-$20.6M
2
FCMI
Foresite Capital Management IV
California
-$12.4M
3
Franklin Resources
Franklin Resources
California
-$10.6M
4
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$9.63M
5
LGM
Logos Global Management
California
-$3.72M
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$2.24M +$2.72M +108,056 +2,050%
Citadel Advisors
27
Citadel Advisors
Florida
$2.19M -$2.11M -83,974 -43%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$2.04M +$980K +38,960 +60%
N
29
Nuveen
North Carolina
$1.89M +$579K +22,992 +32%
Rafferty Asset Management
30
Rafferty Asset Management
New York
$1.79M +$2.06M +81,771 +907%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.68M +$476K +18,897 +29%
JP Morgan Chase
32
JP Morgan Chase
New York
$1.28M +$691K +27,454 +73%
BFM
33
Boothbay Fund Management
New York
$1.08M +$647K +25,719 +88%
Bank of America
34
Bank of America
North Carolina
$973K +$1.15M +45,741 +1,297%
Voloridge Investment Management
35
Voloridge Investment Management
Florida
$973K +$1.24M +49,246 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$863K +$406K +16,139 +59%
California Public Employees Retirement System
37
California Public Employees Retirement System
California
$729K -$85.2K -3,386 -8%
Swiss National Bank
38
Swiss National Bank
Switzerland
$681K – – –
Wells Fargo
39
Wells Fargo
California
$676K -$37K -1,469 -4%
Public Employees Retirement Association of Colorado
40
Public Employees Retirement Association of Colorado
Colorado
$641K +$817K +32,467 New
AAA
41
Affinity Asset Advisors
New York
$593K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$565K +$156K +6,186 +28%
Temasek Holdings
43
Temasek Holdings
Singapore
$539K +$686K +27,272 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$442K -$101K -4,000 -15%
PMAM
45
Penn Mutual Asset Management
Pennsylvania
$439K +$327K +12,987 +141%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$417K +$116K +4,600 +28%
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
$412K – – –
Deutsche Bank
48
Deutsche Bank
Germany
$378K +$135K +5,378 +39%
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$329K +$135K +5,379 +48%
ProShare Advisors
50
ProShare Advisors
Maryland
$292K +$72.9K +2,897 +24%
1
2
3 4

PCVX Hedge Fund Activity: Q1 2021 in Review

74 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Vaxcyte (PCVX) for Q1 2021, worth a combined $868M — down 22% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of PCVX and 9 opened new positions — a net loss of 9 holders — while 13 trimmed existing stakes and 39 added.

The largest buyer was Vanguard Group, adding an estimated $33.3M. The largest seller was Pivotal bioVenture Partners Investment Advisor, cutting an estimated $20.6M.

  • 74 institutional investors held Vaxcyte (PCVX) as of Q1 2021, down from 83 in Q4 2020.
  • Funds reported $868M of Vaxcyte stock for Q1 2021, down 22% quarter-over-quarter.
  • 9 funds opened new Vaxcyte positions in Q1 2021 and 18 closed out, a net change of -9 holders.
  • The largest Vaxcyte buyer in Q1 2021 was Vanguard Group, an estimated $33.3M added.
  • The largest Vaxcyte seller in Q1 2021 was Pivotal bioVenture Partners Investment Advisor, an estimated $20.6M sold.

Based on aggregated 13F filings for Q1 2021.